APA (7th ed.) Citation

Wei, J., Lan, G., Zhang, W., Ran, W., Wei, Y., Liu, X., . . . Gao, J. (2025). Targeting FDX1 by trilobatin to inhibit cuproptosis in doxorubicin‐induced cardiotoxicity. British Journal of Pharmacology, 182(11), 2409. https://doi.org/10.1111/bph.17468

Chicago Style (17th ed.) Citation

Wei, Jiajia, et al. "Targeting FDX1 by Trilobatin to Inhibit Cuproptosis in Doxorubicin‐induced Cardiotoxicity." British Journal of Pharmacology 182, no. 11 (2025): 2409. https://doi.org/10.1111/bph.17468.

MLA (9th ed.) Citation

Wei, Jiajia, et al. "Targeting FDX1 by Trilobatin to Inhibit Cuproptosis in Doxorubicin‐induced Cardiotoxicity." British Journal of Pharmacology, vol. 182, no. 11, 2025, p. 2409, https://doi.org/10.1111/bph.17468.